RNXT

RenovoRx, Inc. RNXT

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,591 of 2,925

Why it scores 26Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$909.0K

Quarter to Jun 30

Net income

$-2.91M

Quarter to Jun 30

Free cash flow

$-2.94M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$9.00M total
AIGH Capital Management LLC
$4.32M+18.9%
Bleichroeder LP
$1.63M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$1.41M-0.2%
GEODE CAPITAL MANAGEMENT, LLC
$415.7K+11.1%
Wealthspire Advisors, LLC
$247.5K0.0%
VANGUARD FIDUCIARY TRUST CO
$235.5K+52.2%
CITADEL ADVISORS LLC
$130.9K-42.6%
NORTHERN TRUST CORP
$83.5K+102.1%
Chicago Partners Investment Group LLC
$78.9K0.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
$73.1K-25.0%
Caprock Group, LLC
$62.7K0.0%
JANE STREET GROUP, LLC
$45.5K+92.2%
Kestra Advisory Services, LLC
$34.8K0.0%
TWO SIGMA SECURITIES, LLC
$34.1K+94.4%
XTX Topco Ltd
$29.4K-1.7%
Clear Creek Financial Management, LLC
$28.5KNew
STATE STREET CORP
$25.6K0.0%
UBS Group AG
$20.4K+523.7%
HighTower Advisors, LLC
$19.6K0.0%
Cetera Investment Advisers
$18.6K+5.6%
Affinity Capital Advisors, LLC
$12.6K0.0%
CAPTRUST FINANCIAL ADVISORS
$12.1K0.0%
RENAISSANCE TECHNOLOGIES LLC
$11.2K-12.3%
MORGAN STANLEY
$7.0K0.0%
Midway Capital Research & Management
$6.2K0.0%
See all 28 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/RNXT

Earnings Per Share

13fpro.ai/company/RNXT

Loading ratio trend…

RNXT key financials by period

Reported revenue, net income and operating margin by fiscal year, from RenovoRx, Inc.'s annual filings on SEC EDGAR.

RenovoRx, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$1.1M$-11.2M—
FY 2024$43.0K$-8.8M—
Source: RNXT filings on SEC EDGAR →

RNXT insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About RenovoRx, Inc. (RNXT): stock profile, AI score and financials

RenovoRx, Inc. (RNXT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores RNXT at 26.3/100 on a composite quality score built from its SEC filings, placing it at rank #2,591 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), RenovoRx, Inc. reports quarterly revenue of $909.0K, net income of $-2.9M, free cash flow of $-2.9M. Top institutional holders of RNXT by reported 13-F value include AIGH Capital Management, Bleichroeder, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. RNXT trades on the Nasdaq exchange and files with the SEC under CIK 1574094. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RNXT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for RenovoRx, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1574094 →